DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez SecordA, Kelley JL. et al.
Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
J Clin Oncol 2011;
29 (07) 825-831
DOI: 10.1200/JCO.2010.30.4386.
We do not assume any responsibility for the contents of the web pages of other providers.